Fengshuang An

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Ministry of Education, Qilu Hospital of Shandong University · ORCID：0000-0001-7617-3790

发表论文 56 篇 · 总被引 2087 次 · h-index 24

代表论文

• Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF‐β/Smad signalling in type 2 diabetic rats (2021 · Journal of Cellular and Molecular Medicine · 被引 210)
• Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway (2019 · Journal of Cellular and Molecular Medicine · 被引 102)
• AIM2 gene silencing attenuates diabetic cardiomyopathy in type 2 diabetic rat model (2019 · Life Sciences · 被引 98)
• AIM2 accelerates the atherosclerotic plaque progressions in ApoE−/− mice (2018 · Biochemical and Biophysical Research Communications · 被引 90)
• Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis (2022 · Cardiovascular Drugs and Therapy · 被引 43)
• Inhibition of PHLPP1 ameliorates cardiac dysfunction via activation of the PI3K/Akt/mTOR signalling pathway in diabetic cardiomyopathy (2020 · Journal of Cellular and Molecular Medicine · 被引 38)